Deciphera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Deciphera Pharmaceuticals

07/02/2023 14:31

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 60 cents​​ per share for the quarter ended in
December. The mean expectation of eleven analysts for the
quarter was for a loss of 56 cents per share.
    * Revenue rose 50.2% to $36.35 million from a year ago;
analysts
expected $35.75 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 60 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Deciphera Pharmaceuticals Inc shares had risen by 2.0%
this
quarter.
    * The company reported a quarterly loss of $45.93 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $23.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
7 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.56          -0.60          Missed
 Sep. 30 2022      -0.58          -0.55          Beat
 Jun. 30 2022      -0.66          -0.60          Beat
 Mar. 31 2022      -0.90          -0.80          Beat